FR3017294B1 - LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY - Google Patents

LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY Download PDF

Info

Publication number
FR3017294B1
FR3017294B1 FR1450964A FR1450964A FR3017294B1 FR 3017294 B1 FR3017294 B1 FR 3017294B1 FR 1450964 A FR1450964 A FR 1450964A FR 1450964 A FR1450964 A FR 1450964A FR 3017294 B1 FR3017294 B1 FR 3017294B1
Authority
FR
France
Prior art keywords
antibiotic
nanocapsules
lipid
therapy
lipid nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1450964A
Other languages
French (fr)
Other versions
FR3017294A1 (en
Inventor
Amokrane Reghal
Gilles Potel
Jacqueline Caillon
Cedric Jacqueline
Karim Asehoune
Maud Gonnet
Thomas Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATLANGRAM
Original Assignee
ATLANGRAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ATLANGRAM filed Critical ATLANGRAM
Priority to FR1450964A priority Critical patent/FR3017294B1/en
Priority to PCT/IB2015/050913 priority patent/WO2015118496A1/en
Publication of FR3017294A1 publication Critical patent/FR3017294A1/en
Application granted granted Critical
Publication of FR3017294B1 publication Critical patent/FR3017294B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

La présente invention se rapporte à des nanocapsules lipidiques comprenant un cœur lipidique liquide ou semi-liquide à température ambiante dans lequel est incorporé au moins un antibiotique, le cœur étant enveloppé d'une enveloppe lipidique solide à température ambiante, et à une composition pharmaceutique comprenant de telles nanocapsules pour traiter ou prévenir une infection bactérienne touchant une articulation, un os ou la peau. La présente invention porte également sur des dispositifs médicaux comprenant de telles nanocapsules ou composition pharmaceutiques.The present invention relates to lipid nanocapsules comprising a liquid or semi-liquid lipid core at ambient temperature in which at least one antibiotic is incorporated, the core being enveloped in a lipid envelope which is solid at ambient temperature, and to a pharmaceutical composition comprising such nanocapsules for treating or preventing bacterial infection affecting a joint, bone or skin. The present invention also relates to medical devices comprising such nanocapsules or pharmaceutical compositions.

FR1450964A 2014-02-07 2014-02-07 LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY Active FR3017294B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1450964A FR3017294B1 (en) 2014-02-07 2014-02-07 LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY
PCT/IB2015/050913 WO2015118496A1 (en) 2014-02-07 2015-02-06 Lipid nanocapsules containing an antibiotic and therapeutic uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1450964A FR3017294B1 (en) 2014-02-07 2014-02-07 LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY

Publications (2)

Publication Number Publication Date
FR3017294A1 FR3017294A1 (en) 2015-08-14
FR3017294B1 true FR3017294B1 (en) 2021-10-01

Family

ID=50624776

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1450964A Active FR3017294B1 (en) 2014-02-07 2014-02-07 LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY

Country Status (2)

Country Link
FR (1) FR3017294B1 (en)
WO (1) WO2015118496A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3679928A1 (en) * 2019-01-08 2020-07-15 Atlangram Gel type pharmaceutical composition for treating/preventing an infection
KR20220020963A (en) 2019-06-14 2022-02-21 데비오팜 인터네셔날 에스 에이 Medicines and uses thereof for treating biofilm-associated bacterial infections
CN112263395B (en) * 2020-09-18 2021-12-14 浙江珍琦护理用品有限公司 Panty-shape diapers convenient to adjust size

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805761B1 (en) 2000-03-02 2002-08-30 Mainelab LIPID NANOCAPSULES, METHOD OF PREPARATION AND USE AS A MEDICAMENT
FR2840532B1 (en) * 2002-06-11 2005-05-06 Ethypharm Sa FURENT LIPID NANOCAPSULES, PROCESS FOR THEIR PREPARATION AND USE AS VECTOR OF ACTIVE (S) PRINCIPLES
FR2916973B1 (en) 2007-06-11 2010-02-26 Univ Angers NANOCAPSULES WITH LIPIDIC HEAD CHARGED WITH HYDROSOLUBLE (S) OR HYDRODISPERSIBLE ACTIVE (S)
FR2916974B1 (en) 2007-06-11 2010-11-26 Univ Angers PROCESS FOR THE PREPARATION OF LIPID NANOPARTICLES
FR2939699B1 (en) 2008-12-12 2011-05-06 Univ Angers PROCESS FOR THE PREPARATION OF LIPID NANOPARTICLES
US9492398B2 (en) * 2011-02-25 2016-11-15 Eydo Pharma Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic

Also Published As

Publication number Publication date
WO2015118496A1 (en) 2015-08-13
FR3017294A1 (en) 2015-08-14
WO2015118496A4 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MA44549A1 (en) Immunoregulatory agents
MA42859B2 (en) Antimicrobial compositions and methods of use thereof.
MA53937B1 (en) Compositions comprising bacterial strains
MA33219B1 (en) SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
NO20080284L (en) Cannabionoid active pharmaceutical ingredient for improved dosage forms
MA38576A1 (en) Colchicine extended-release formulations and methods of using the same
FR3017294B1 (en) LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY
BR112021021857A2 (en) Methods for forming inclusion complexes with hydrophilic beta-cyclodextrin derivatives and compositions thereof
BR112019000849A2 (en) antibacterial system cleaning compositions and method of manufacture thereof
MA39346A1 (en) Fusion-linked substituted heterocycles as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
FR3065371B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION INCLUDING AT LEAST AMITRIPTYLINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
MA29723B1 (en) COMPOUNDS
MA55291A (en) METHOD FOR THE MANUFACTURE OF STABLE BACTERIAL EXTRACTS AND THEIR USE AS PHARMACEUTICAL PRODUCTS
Rueda‐Fernández et al. Effect of the most common wound antiseptics on human skin fibroblasts
MA52438A (en) STERILE OR STERILIZED PACKAGING FOR THE ADMINISTRATION OF MEDICINAL OR NUTRITIONAL SUBSTANCES.
MA54276B1 (en) MONTELUKAST FOR THE TREATMENT OF HAND OSTEOARTHRITIS
FR3064180B1 (en) FORMULATIONS COMPRISING ACTIVE INGREDIENTS FROM THE MURRAYA KOENIGII PLANT
FR3076711B1 (en) COMPOSITION INCLUDING HYDROXYCHLOROQUINE AND THERAPEUTIC USE
BR0313589A (en) Use of fermented wheat germ extract as anti-inflammatory agent
FR3057778B1 (en) NEW ACTIVE ADIPOCYTE COMPOSITIONS
MA38871B2 (en) Lubricant complex for the mouth
FR3061013B1 (en) COMPOSITION CONTAINING DIGENEASIDE, PROCESS FOR OBTAINING SAME AND ITS COSMETIC, VETERINARY OR NUTRACEUTICAL USE
MX2020007750A (en) Pharmaceutical package for prevention and/or treatment of covid-19 disease and use thereof.
FR3086542B1 (en) USE OF AN AGAVE EXTRACT TO STRENGTHEN THE BARRIER FUNCTION OF THE SKIN, SCALP AND / OR MUCOSAUSES AND MODULATE THE SKIN MICROBIOTE
FR3085679B1 (en) SIMILAR COMPOUNDS OF SQUALAMINE AND THEIR MEDICAL USE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11